Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 The Global Interventional Neurology Market is Expected to Grow at a CAGR of 7% from 2010 through 2017 The US market for interventional neurology was valued at $339.3m in 2010 and is forecast to grow at a CAGR of 8% to reach $566m in 2017. The US is the biggest market in the sector, making up 41% of the global interventional neurology market in 2010. In the US, demand for interventional neurology products is mainly driven by the development of embolization procedures. The market is expected to be driven by the increasing awareness about aneurysm causing diseases and treatment procedures. In the US, navigational systems were the largest market segment, valued at $154.1m, in 2010. In 2017, the trend in the market will change and the embolic systems market will grow at a CAGR of 9% to be the largest segment, reaching $257m. The market is shifting towards minimally invasive treatment and away from surgical treatment options. This is increasing the market value of the endovascular treatment option for aneurysms. Instead of open operations, this minimally invasive technique uses X-ray imaging, catheters, and various embolic systems and neurovascular stents to treat diseases of the blood vessels of the brain and spine. The advantages of coil treatment include the speed of procedure and the use of an endovascular approach rather than craniotomy. This shift is also increasing treatment options for patients with multiple aneurysms, which can now be treated at the same time. Interventional neurology products are not only used for treating aneurysms. Many products can be used for treating diseases such as ischemic stroke, brain arteriovenous malformation (AVM) and dural arteriovenous fistula and vasospasm, amongst others. Many companies have products in the pipeline which can be used for aneurysms as well as for ischemic strokes. The second target disease for using interventional neurology products is AVM. The embolization procedure is helpful when performed before surgery or radiation for AVM. It is useful in reducing bleeding during surgery and also helps in reducing the size of the AVM to be radiated. For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=InterventionalNeurology-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to2017&Title=Medical_Devices&ReportType=Industry_Report Boston Scientific, Johnson & Johnson, Covidien plc and Terumo were the leading companies in the interventional neurology market in 2010, accounting for 94% of the market. Boston Scientific was the market leader with a 31% share. However, it is expected that the competitive landscape will change as Boston recently sold all of its neurovascular products to Stryker.
GlobalDataâ€™s new report, â€œInterventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017â€? provides key data, information and analysis on the global interventional neurology market. The report provides market landscape, competitive landscape and market trends information on the interventional neurology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Interventional-NeurologyGlobal-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to2017&Title=Medical_Devices&ReportType=Industry_Report Visit our report store: http://www.globaldata.com For more details contact: email@example.com North America: +1 646 395 5477 Europe: +44 207 753 4299 +44 1204 543 533 Asia Pacific: +91 40 6616 6782